PDIA5 and glioma: Furthermore, PDIA5 can promote ATF6 disulfide bond rearrangement of ATF6α under ER stress, maintaining its active conformation, and conferring chemotherapy resistance to cancer cells, thus affecting the progression of patients with glioma 19,20.